Somna Therapeutics Seeks FDA Approval for New Device to Relieve Serious Acid Reflux

December 9th, 2013 Tom Fowler GI, Surgery

Somna Therapeutics (Germantown, WI) filed a petition with the FDA for a new externally-worn, non-invasive medical device for the treatment of symptoms caused by acid reflux into the throat and lungs in patients suffering from extraesophageal reflux disease. In laryngopharyngeal reflux sufferers, the UES relaxes too much, allowing acids to rise. The Reza-Band UES Assist Device applies a small amount of precise external pressure on the UES between the cricoid cartilage and cervical vertebrae, preventing reflux into the larynx, pharynx and lungs.

Developed by Dr. Reza Shaker, a gastroenterologist at the Medical College of Wisconsin, the device is a simple adjustable comfort band attached to a cushion and frame and is mainly worn during sleep to prevent excessive relaxation. It’s engineered to prevent excessive upper esophageal sphincter (UES) relaxation during sleep and it’s been through clinical trials that have shown promising results that the company is taking to the FDA to receive final market approval.

Product page: Reza-Band UES Assist Device…

Milwaukee Journal-Sentinel: Somna Therapeutics seeks approval for new device to relieve serious acid reflux…

Upcoming conferences

october

18octallday19alldayWorld Congress on Polycystic Ovarian Syndrome and Fertility, 2018Abu Dhabi, UAE

18octallday19alldayManaging Your Complaints and Obstacles in Post-Market Requirements -- Results from Top Medical Device Observations During an InspectionMinneapolis, MN, USA

Event Details

Post-Market activities, Complaint Handling, MDRs, and Recalls are expensive, time consuming, and often lead to more serious financial consequences. Over 80% of FDA Inspection target observations for lack of compliance in these areas.

By attending this seminar, you will discover:

How to overcome one of the biggest obstacles device manufacturers face
How the FDA expects you to develop and implement proper handling of complaints reportable or non-reportable, product complaint handling and documentation
How and when to file Medical Device Reports (MDR), effective and appropriate communication with the appropriate regulatory agencies in the event of a recall.
How to conduct a correction and removal actions to avoid a recall crisis, including required recordkeeping, expectation from FDA and other regulatory agencies in the event of a recall and key factors in implementing and maintaining compliance with the regulations and real life experiences of FDA.

**New course materials have been added, updated content will include:

Creating Standard Operating Systems (SOPs) for Post-Market Quality Systems and
What to expect from the changes in ORA with Inspection Structure Realignment

This Seminar will have you stop spinning your wheels with nonessential activities, and leave you with a comprehensive learning package that only Rita Hoffman, a former FDA CDRH Recall Branch Chief with experience across the device, drug and veterinary industries can provide.

Spend one and a half days in an interactive course led by Ms. Rita Hoffman, Former FDA CDRH Recall Branch Chief with over 36 years with FDA and leading Industry Expert, who will provide the participants with tools to minimize risk of regulatory enforcement actions.

Time

october 18 (Thursday) - 19 (Friday)

Organizer

Compliance Online 80068SEM

Learn More

Calendar GoogleCal

18octallday19allday18th Global Ophthalmology, Optometry and Glaucoma Conference, 2018Helsinki, Finland

18octallday19alldayBiology and Pathology of Infectious Disease Conference, 2018Helsinki, Finland

18octallday19allday14th Global Biomarkers Summit, 2018Amsterdam, Netherlands

22octallday23alldayInternational Conference on Breast Cancer, 2013Vancouver, British Columbia, Canada